Prediction of PD-L1 Expression in Neuroblastoma via Computational Modeling
Immunotherapy is a promising new therapeutic approach for neuroblastoma (NBM): an anti-GD2 vaccine combined with orally administered soluble beta-glucan is undergoing a phase II clinical trial and nivolumab and ipilimumab are being tested in recurrent and refractory tumors. Unfortunately, predictive...
| Main Authors: | , , , , , , , , , , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
MDPI AG
2019-08-01
|
| 叢編: | Brain Sciences |
| 主題: | |
| 在線閱讀: | https://www.mdpi.com/2076-3425/9/9/221 |